Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension.
暂无分享,去创建一个
Y. Fung | J. Yuan | C. V. Remillard | L. Rubin | Wei Huang | M. Mandegar
[1] A. Matsumori,et al. Endothelin antagonism with bosentan: current status and future perspectives. , 2006, Cardiovascular drug reviews.
[2] I. Fantozzi,et al. Hypoxia increases AP-1 binding activity by enhancing capacitative Ca2+ entry in human pulmonary artery endothelial cells. , 2003, American journal of physiology. Lung cellular and molecular physiology.
[3] N. Voelkel,et al. Circulating endothelial cells in pulmonary hypertension , 2003, Thrombosis and Haemostasis.
[4] P. Thistlethwaite,et al. Induction of pulmonary hypertension by an angiopoietin 1/TIE2/serotonin pathway , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[5] K. Brown,et al. Expression of human herpesvirus 8 in primary pulmonary hypertension. , 2003, The New England journal of medicine.
[6] I. Fantozzi,et al. Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells. , 2003, American journal of physiology. Lung cellular and molecular physiology.
[7] S. Eddahibi,et al. Role of VEGF-B in the lung during development of chronic hypoxic pulmonary hypertension. , 2003, American journal of physiology. Lung cellular and molecular physiology.
[8] D. Stewart,et al. Protective Role of Angiopoietin-1 in Experimental Pulmonary Hypertension , 2003, Circulation research.
[9] G. Yancopoulos,et al. Angiopoietin-1 and pulmonary hypertension: cause or cure? , 2003, Circulation research.
[10] P. Thistlethwaite,et al. Signaling molecules in nonfamilial pulmonary hypertension. , 2003, The New England journal of medicine.
[11] Ying Yu,et al. PDGF stimulates pulmonary vascular smooth muscle cell proliferation by upregulating TRPC6 expression. , 2003, American journal of physiology. Cell physiology.
[12] Lan Zhao,et al. Beneficial Effects of Phosphodiesterase 5 Inhibition in Pulmonary Hypertension Are Influenced by Natriuretic Peptide Activity , 2003, Circulation.
[13] R. Nemenoff,et al. Hypoxic activation of adventitial fibroblasts: role in vascular remodeling. , 2002, Chest.
[14] H. Stein,et al. Aberrantly expressed c‐Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF‐κB , 2002, The EMBO journal.
[15] R. Barst,et al. Bosentan therapy for pulmonary arterial hypertension. , 2002, The New England journal of medicine.
[16] Anja Nohe,et al. The Mode of Bone Morphogenetic Protein (BMP) Receptor Oligomerization Determines Different BMP-2 Signaling Pathways* , 2002, The Journal of Biological Chemistry.
[17] A. Chiavegato,et al. Contribution of Adventitial Fibroblasts to Neointima Formation and Vascular Remodeling: From Innocent Bystander to Active Participant , 2001, Circulation research.
[18] J. Morrow,et al. Increased levels of prostaglandin D(2) suggest macrophage activation in patients with primary pulmonary hypertension. , 2001, Chest.
[19] M. Humbert,et al. Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. , 2001, The Journal of clinical investigation.
[20] N. Voelkel,et al. The pathobiology of pulmonary hypertension. Endothelium. , 2001, Clinics in chest medicine.
[21] R. Trembath,et al. Altered Growth Responses of Pulmonary Artery Smooth Muscle Cells From Patients With Primary Pulmonary Hypertension to Transforming Growth Factor-&bgr;1 and Bone Morphogenetic Proteins , 2001, Circulation.
[22] M. Humbert,et al. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. , 2001, The New England journal of medicine.
[23] John Arul Phillips,et al. Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred. , 2001, The New England journal of medicine.
[24] P. Thistlethwaite,et al. Human angiopoietin gene expression is a marker for severity of pulmonary hypertension in patients undergoing pulmonary thromboendarterectomy. , 2001, The Journal of thoracic and cardiovascular surgery.
[25] Ying Yu,et al. Bcl-2 decreases voltage-gated K+ channel activity and enhances survival in vascular smooth muscle cells. , 2001, American journal of physiology. Cell physiology.
[26] D. Mottet,et al. HIF‐1 and AP‐1 Cooperate to Increase Gene Expression in Hypoxia: Role of MAP Kinases , 2001, IUBMB life.
[27] Thomas A. Mustoe, MD, FACS,et al. Oxygen in wound healing: More than a nutrient , 2001, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[28] Wei-wei Wang,et al. Dexfenfluramine as a mitogen signals through the formation of superoxide anion , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] Michael R. Pinsky,et al. Respiratory-circulatory interactions in health and disease , 2001 .
[30] O. Platoshyn,et al. Activation of K+ channels induces apoptosis in vascular smooth muscle cells. , 2001, American journal of physiology. Cell physiology.
[31] P. Aaronson,et al. Hypoxia induces the release of a pulmonary-selective, Ca(2+)-sensitising, vasoconstrictor from the perfused rat lung. , 2001, Cardiovascular research.
[32] M. Hamon,et al. Dexfenfluramine-associated changes in 5-hydroxytryptamine transporter expression and development of hypoxic pulmonary hypertension in rats. , 2001, The Journal of pharmacology and experimental therapeutics.
[33] N. Voelkel,et al. Gene Expression Patterns in the Lungs of Patients With Primary Pulmonary Hypertension: A Gene Microarray Analysis , 2001, Circulation research.
[34] H. Ohira,et al. Effect of a serotonin receptor antagonist on interleukin-6-induced pulmonary hypertension in rats. , 2001, Chest.
[35] P. Hirth,et al. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[36] C. L. Bailey,et al. Upregulated TRP and enhanced capacitative Ca(2+) entry in human pulmonary artery myocytes during proliferation. , 2001, American journal of physiology. Heart and circulatory physiology.
[37] Sakae Tanaka,et al. Negative Regulation of BMP/Smad Signaling by Tob in Osteoblasts , 2000, Cell.
[38] H. Lodish,et al. Critical Role of Smads and AP-1 Complex in Transforming Growth Factor-β-dependent Apoptosis* , 2000, The Journal of Biological Chemistry.
[39] G. Semenza. Oxygen-regulated transcription factors and their role in pulmonary disease , 2000, Respiratory research.
[40] M. Gatzoulis,et al. Sildenafil in primary pulmonary hypertension. , 2000, The New England journal of medicine.
[41] C. L. Bailey,et al. Sustained membrane depolarization and pulmonary artery smooth muscle cell proliferation. , 2000, American journal of physiology. Cell physiology.
[42] P. Friedman,et al. Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension. A morphometric and immunohistochemical study. , 2000, American journal of respiratory and critical care medicine.
[43] S. Hodge,et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. , 2000, American journal of human genetics.
[44] M. Maclean,et al. 5‐hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension , 2000, British journal of pharmacology.
[45] Y Ishizaki,et al. Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[46] A. Hislop,et al. Prenatal origins of human intrapulmonary arteries: formation and smooth muscle maturation. , 2000, American journal of respiratory cell and molecular biology.
[47] K. Lesch,et al. Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. , 2000, The Journal of clinical investigation.
[48] R. Rothman,et al. Chronic treatment with phentermine combined with fenfluramine lowers plasma serotonin. , 2000, The American journal of cardiology.
[49] J. Massagué,et al. Controlling TGF-β signaling , 2000, Genes & Development.
[50] G. Kay,et al. Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. , 2000, Circulation research.
[51] J. Berkenbosch,et al. Decreased synthesis and vasodilation to nitric oxide in piglets with hypoxia-induced pulmonary hypertension. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[52] J. Massagué,et al. OAZ Uses Distinct DNA- and Protein-Binding Zinc Fingers in Separate BMP-Smad and Olf Signaling Pathways , 2000, Cell.
[53] K. Alitalo,et al. Current biology of VEGF-B and VEGF-C. , 1999, Current opinion in biotechnology.
[54] R. Weinberg,et al. SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[55] J. Darnell,et al. Interacting Regions in Stat3 and c-Jun That Participate in Cooperative Transcriptional Activation , 1999, Molecular and Cellular Biology.
[56] R. Rothman,et al. Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension. , 1999, Circulation.
[57] K. Münter,et al. Endothelin-1 and endothelin receptor antagonists in cardiovascular remodeling. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[58] R. L. Williams,et al. Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth. , 1999, The American journal of pathology.
[59] Wei-wei Wang,et al. Serotonin stimulates mitogen-activated protein kinase activity through the formation of superoxide anion. , 1999, American journal of physiology. Lung cellular and molecular physiology.
[60] C. Bortner,et al. Caspase Independent/Dependent Regulation of K+, Cell Shrinkage, and Mitochondrial Membrane Potential during Lymphocyte Apoptosis* , 1999, The Journal of Biological Chemistry.
[61] M. Blaustein,et al. Sodium/calcium exchange: its physiological implications. , 1999, Physiological reviews.
[62] K. Yamato,et al. Differential Inhibition of Smad6 and Smad7 on Bone Morphogenetic Protein- and Activin-mediated Growth Arrest and Apoptosis in B Cells* , 1999, The Journal of Biological Chemistry.
[63] J. Massagué,et al. A Smad Transcriptional Corepressor , 1999, Cell.
[64] D. Rodman,et al. Hypoxia inhibits increased ETB receptor-mediated NO synthesis in hypertensive rat lungs. , 1999, The American journal of physiology.
[65] M. Martres,et al. Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin. , 1999, Circulation research.
[66] Louis Wj. Primary pulmonary hypertension and anorectic drugs. , 1999 .
[67] G. Garcı́a-Cardeña,et al. Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[68] A. Fishman. Aminorex to fen/phen: an epidemic foretold. , 1999, Circulation.
[69] D. Faller. ENDOTHELIAL CELL RESPONSES TO HYPOXIC STRESS , 1999, Clinical and experimental pharmacology & physiology.
[70] A. Lopes,et al. Circulating von Willebrand factor antigen as a predictor of short-term prognosis in pulmonary hypertension. , 1998, Chest.
[71] J. Orens,et al. Dysfunctional voltage-gated K+ channels in pulmonary artery smooth muscle cells of patients with primary pulmonary hypertension. , 1998, Circulation.
[72] R. Yen,et al. Comparison of Theory and Experiment in Pulsatile Flow in Cat Lung , 1998, Annals of Biomedical Engineering.
[73] M. Rabinovitch,et al. Elastase and the pathobiology of unexplained pulmonary hypertension. , 1998, Chest.
[74] A. Giaid. Nitric oxide and endothelin-1 in pulmonary hypertension. , 1998, Chest.
[75] Y. Lazebnik,et al. Caspases: enemies within. , 1998, Science.
[76] J. Yuan,et al. Action of fenfluramine on voltage- gated K+ channels in human pulmonary-artery smooth-muscle cells , 1998, The Lancet.
[77] S. Kourembanas,et al. Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension. , 1998, American journal of respiratory cell and molecular biology.
[78] Keli Xu,et al. Calcium oscillations increase the efficiency and specificity of gene expression , 1998, Nature.
[79] C. Boshoff,et al. Human herpesvirus type 8 and Kaposi's sarcoma. , 1998, Journal of the National Cancer Institute. Monographs.
[80] R. Goldie. Endothelin receptor subtypes: distribution and function in the lung. , 1998, Pulmonary pharmacology & therapeutics.
[81] M. Juhaszova,et al. Attenuated K+ channel gene transcription in primary pulmonary hypertension , 1998, The Lancet.
[82] K. Shroyer,et al. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. , 1998, The Journal of clinical investigation.
[83] B. Fanburg,et al. Superoxide as an intermediate signal for serotonin-induced mitogenesis. , 1998, Free radical biology & medicine.
[84] Y. Tsujimoto,et al. Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[85] H. Bading,et al. Mechanisms controlling gene expression by nuclear calcium signals. , 1998, Cell calcium.
[86] J. Massagué,et al. Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. , 1998, Genes & development.
[87] C. Bortner,et al. A Primary Role for K+ and Na+ Efflux in the Activation of Apoptosis* , 1997, The Journal of Biological Chemistry.
[88] Kohei Miyazono,et al. TGF-β signalling from cell membrane to nucleus through SMAD proteins , 1997, Nature.
[89] M. Berridge,et al. Nuclear calcium signalling by individual cytoplasmic calcium puffs , 1997, The EMBO journal.
[90] K. Miyazono,et al. Smad6 inhibits signalling by the TGF-β superfamily , 1997, Nature.
[91] R. Penner,et al. Store depletion and calcium influx. , 1997, Physiological reviews.
[92] Huiling He,et al. Maintenance of Calcium Homeostasis in the Endoplasmic Reticulum by Bcl-2 , 1997, The Journal of cell biology.
[93] P. Huang,et al. Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS 3) gene. , 1997, Circulation research.
[94] D. Sawyer,et al. Early fetal development of lung vasculature. , 1997, American journal of respiratory cell and molecular biology.
[95] B. Fanburg,et al. A new role for an old molecule: serotonin as a mitogen. , 1997, The American journal of physiology.
[96] K. Stenmark,et al. Hypoxia increases bromodeoxyuridine labeling indices in bovine neonatal pulmonary arteries. , 1997, American journal of respiratory cell and molecular biology.
[97] N. Voelkel,et al. Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection. , 1997, Human pathology.
[98] K. McQuaid,et al. Endothelial barrier dysfunction and oxidative stress: roles for nitric oxide? , 1997, Experimental physiology.
[99] T. Evans,et al. Nitric oxide, the biological mediator of the decade: fact or fiction? , 1997, The European respiratory journal.
[100] D. Green,et al. The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis , 1997, Science.
[101] Hilmar Bading,et al. Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression , 1997, Nature.
[102] R. Yen,et al. Morphometry of the human pulmonary vasculature. , 1996, Journal of applied physiology.
[103] M. Houslay,et al. 5‐Hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats , 1996, British journal of pharmacology.
[104] R. Marlar,et al. Coagulation and fibrinolytic profiles in patients with severe pulmonary hypertension. , 1996, Chest.
[105] Lieve Moons,et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele , 1996, Nature.
[106] X. J. Yuan,et al. Voltage-gated K+ currents regulate resting membrane potential and [Ca2+]i in pulmonary arterial myocytes. , 1995, Circulation research.
[107] A Giaid,et al. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. , 1995, The New England journal of medicine.
[108] M. Nelson,et al. Physiological roles and properties of potassium channels in arterial smooth muscle. , 1995, The American journal of physiology.
[109] N. Voelkel,et al. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. , 1995, The Journal of clinical investigation.
[110] N. Allbritton,et al. Source of nuclear calcium signals. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[111] Andrew P. Somlyo,et al. Signal transduction and regulation in smooth muscle , 1994, Nature.
[112] Carl Nathan,et al. Nitric oxide synthases: Roles, tolls, and controls , 1994, Cell.
[113] T. Saruta,et al. Pressure promotes DNA synthesis in rat cultured vascular smooth muscle cells. , 1994, The Journal of clinical investigation.
[114] M. Yanagisawa. The endothelin system. A new target for therapeutic intervention. , 1994, Circulation.
[115] B. Groves,et al. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. , 1994, The American journal of pathology.
[116] G S Kassab,et al. Diameter-defined Strahler system and connectivity matrix of the pulmonary arterial tree. , 1994, Journal of applied physiology.
[117] Y. Fung,et al. Material coefficients of the strain energy function of pulmonary arteries in normal and cigarette smoke-exposed rats. , 1993, Journal of biomechanics.
[118] H. Mogami,et al. Stimulation of calcium entry is prerequisite for DNA synthesis induced by platelet-derived growth factor in vascular smooth muscle cells. , 1993, Biochemical and biophysical research communications.
[119] G. Isenberg,et al. Membrane potential modulates inositol 1,4,5‐trisphosphate‐mediated Ca2+ transients in guinea‐pig coronary myocytes. , 1993, The Journal of physiology.
[120] P. Barnes,et al. Nitric oxide and lung disease. , 1993, Thorax.
[121] Y C Fung,et al. Changes in the structure and mechanical properties of pulmonary arteries of rats exposed to cigarette smoke. , 1993, The American review of respiratory disease.
[122] G S Kassab,et al. Morphometry of the dog pulmonary venous tree. , 1993, Journal of applied physiology.
[123] M. Blaustein,et al. Physiological effects of endogenous ouabain: control of intracellular Ca2+ stores and cell responsiveness. , 1993, The American journal of physiology.
[124] E. Oldfield,et al. Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. , 1993, The American journal of physiology.
[125] M. Berridge. Inositol trisphosphate and calcium signalling , 1993, Nature.
[126] Y C Fung,et al. Changes in the rheological properties of blood vessel tissue remodeling in the course of development of diabetes. , 1992, Biorheology.
[127] B. Groves,et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. , 1992, The New England journal of medicine.
[128] Y. Fung,et al. Influence of STZ-Induced Diabetes on Zero-Stress States of Rat Pulmonary and Systemic Arteries , 1992, Diabetes.
[129] Y C Fung,et al. Changes of zero-stress state of rat pulmonary arteries in hypoxic hypertension. , 1991, Journal of applied physiology.
[130] B. Marshall,et al. Hypoxic contraction of cultured pulmonary vascular smooth muscle cells. , 1990, American journal of respiratory cell and molecular biology.
[131] A. Jaffe,et al. Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension. , 1990, Circulation.
[132] M. Blaustein,et al. Contrasting effects of hypoxia on tension in rat pulmonary and mesenteric arteries. , 1990, The American journal of physiology.
[133] J. Vane,et al. Regulatory functions of the vascular endothelium. , 1990, The New England journal of medicine.
[134] J B Patlak,et al. Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone. , 1990, The American journal of physiology.
[135] B. Madden,et al. The ultrastructure of plexogenic pulmonary arteriopathy , 1990, The Journal of pathology.
[136] B. Fanburg,et al. Serotonin uptake and configurational change of bovine pulmonary artery smooth muscle cells in culture , 1989, Journal of cellular physiology.
[137] L. Rubin,et al. Primary pulmonary hypertension. , 1997, The New England journal of medicine.
[138] L. Hoyer,et al. von Willebrand factor abnormalities in primary pulmonary hypertension. , 1987, The American review of respiratory disease.
[139] K. Morgan,et al. Stimulus‐specific patterns of intracellular calcium levels in smooth muscle of ferret portal vein. , 1984, The Journal of physiology.
[140] Y C Fung,et al. Morphometry of cat's pulmonary arterial tree. , 1984, Journal of biomechanical engineering.
[141] Y C Fung,et al. Analysis of blood flow in cat's lung with detailed anatomical and elasticity data. , 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.
[142] C. William Hall,et al. Biomedical Engineering II Recent Developments , 1983 .
[143] Y C Fung,et al. Morphometry of cat pulmonary venous tree. , 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.
[144] R. Michel,et al. Partitioning of pulmonary vascular resistance in dogs by arterial and venous occlusion. , 1982, Journal of applied physiology: respiratory, environmental and exercise physiology.
[145] Y. Fung,et al. Biomechanics: Mechanical Properties of Living Tissues , 1981 .
[146] B. Zweifach,et al. Pre- and postcapillary resistances in cat mesentery. , 1974, Microvascular research.
[147] G Cumming,et al. Morphometry of the Human Pulmonary Arterial Tree , 1973, Circulation research.
[148] Y C Fung,et al. Elasticity of the Pulmonary Alveolar Sheet , 1972, Circulation research.
[149] Y. Fung,et al. Pulmonary Alveolar Blood Flow , 1972, Circulation research.
[150] Y C Fung,et al. Theory of sheet flow in lung alveoli. , 1969, Journal of applied physiology.
[151] A B DuBois,et al. Longitudinal distribution of vascular resistance in the pulmonary arteries, capillaries, and veins. , 1968, The Journal of clinical investigation.
[152] E. Weibel. Morphometry of the Human Lung , 1965, Springer Berlin Heidelberg.
[153] E. Weibel,et al. Architecture of the Human Lung , 1962, Science.
[154] A B DUBOIS,et al. Mechanics of pulmonary circulation in isolated rabbit lungs. , 1959, The American journal of physiology.
[155] P. Riederer,et al. Organization of the human serotonin transporter gene , 2005, Journal of Neural Transmission / General Section JNT.
[156] S. Archer,et al. Hypoxic pulmonary vasoconstriction. , 2005, Journal of applied physiology.
[157] J. Yuan. Hypoxic pulmonary vasoconstriction : cellular and molecular mechanisms , 2004 .
[158] A. Verin,et al. Molecular Mechanisms of Thrombin-Induced Endothelial Cell Permeability , 2004, Biochemistry (Moscow).
[159] Wei Huang,et al. Tissue Remodeling of Rat Pulmonary Artery in Hypoxic Breathing. II. Course of Change of Mechanical Properties , 2004, Annals of Biomedical Engineering.
[160] J. Yuan,et al. Activation of K+ channels: an essential pathway in programmed cell death. , 2004, American journal of physiology. Lung cellular and molecular physiology.
[161] M. Humbert,et al. BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. , 2001, American journal of human genetics.
[162] J. Yuan,et al. Pathophysiology of pulmonary hypertension , 2001 .
[163] B. Fanburg,et al. Association of Tyr phosphorylation of GTPase-activating protein with mitogenic action of serotonin. , 1997, The American journal of physiology.
[164] 阿部 博之,et al. Data book on mechanical properties of living cells, tissues, and organs , 1996 .
[165] A. Ruf,et al. Ultrastructural aspects of platelet adhesion on subendothelial structures. , 1995, Seminars in thrombosis and hemostasis.
[166] P. Aaronson,et al. Hypoxic vasoconstriction and intracellular Ca2+ in pulmonary arteries: evidence for PKC-independent Ca2+ sensitization. , 1995, The American journal of physiology.
[167] B. Fanburg,et al. Serotonin produces both hyperplasia and hypertrophy of bovine pulmonary artery smooth muscle cells in culture. , 1994, The American journal of physiology.
[168] P. Celada,et al. Effects of chronic treatment with dexfenfluramine on serotonin in rat blood, brain and lung tissue. , 1994, Life sciences.
[169] R. Crystal,et al. The Lung: Scientific Foundations , 1991 .
[170] R. N. Vaishnav,et al. ESTIMATION OF RESIDUAL STRAINS IN AORTIC SEGMENTS , 1983 .